TSX runs higher on rate cut expectations
PARIS, FRANCE - Novacyt (EPA:ALNOV) S.A. (EURONEXT GROWTH:ALNOV; AIM:NCYT), a global molecular diagnostics company, has announced that its Annual General Meeting (AGM) is set to take place at the Hilton Hotel, Paris Charles de Gaulle Airport, on Thursday, June 19, 2025. The meeting is scheduled for 1 pm CEST/12 pm BST and will be accessible to shareholders in person.
The company, known for its extensive portfolio of molecular assays and instrumentation, stated that a video recording of the AGM proceedings will be made available on the Novacyt website shortly after the event concludes. This move ensures that stakeholders unable to attend can stay informed about the company’s developments and decisions made during the AGM.
Novacyt operates across three main business segments: Clinical, Instrumentation, and Research Use Only. Its clinical segment offers a variety of in vitro diagnostic products and services, focusing on reproductive health, precision medicine, and infectious diseases. The instrumentation segment boasts advanced DNA sample preparation platforms and rapid PCR machines, while the Research Use Only segment provides high-performance qPCR assays and workflows for various sectors, including human health and environmental research.
With headquarters in Le Vésinet, France, and offices in the UK, Singapore, the US, and Canada, Novacyt maintains a commercial presence in over 65 countries. The company is listed on both the London and Paris stock exchanges under the tickers NCYT and ALNOV, respectively.
This information is based on a press release statement from Novacyt S.A. and provides shareholders and interested parties with the necessary details about the upcoming AGM, reflecting the company’s commitment to transparency and stakeholder engagement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.